Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients

Clinical trial NCT01213641 · COMPLETED

Trial details

NCT number: NCT01213641
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Study type: OBSERVATIONAL

Cryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)Neonatal Onset Multisystem Inflam Disease (NOMID)

Start date: 2009-11-01
Primary completion: 2015-12-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.